We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Issues Draft Guidance on Biosimilar Product Development

News   Feb 13, 2012

 
FDA Issues Draft Guidance on Biosimilar Product Development
 
 
 

RELATED ARTICLES

The "Secret Weapon" of Virus-Neutralizing Antibodies

News

A new study in mice has explored why certain antibodies are highly effective in protecting the body against debilitating viruses like chikungunya.

READ MORE

Antibody Therapy That Trains Phagocytes to Destroy Tumors Is Tested in Patients

News

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

READ MORE

Could a Superior Therapeutic Approach for MS Be on the Horizon?

News

Researchers show compounds based on chloroindazole reduce inflammation as well as promote neuroprotection and remyelination, improving the primary symptoms in a mouse model of multiple sclerosis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE